Clinical Trial Update: Efficacy Study of Genexol-PM and Cisplatin in Locally Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating Genexol-PM with cisplatin in locally advanced head and neck squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Genexol-PM (paclitaxel)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED